Attainment and maintenance of platelet inhibition through standard dosing of abciximab in patients undergoing percutaneous coronary intervention - Response

Authors
Steinhubl, SR Kottke-Marchant, K Moliterno, DJ Rosenthal, M Topol, EJ Lincoff, AM Coller, BS
Citation
Sr. Steinhubl et al., Attainment and maintenance of platelet inhibition through standard dosing of abciximab in patients undergoing percutaneous coronary intervention - Response, CIRCULATION, 102(25), 2000, pp. E186-E186
Citations number
2
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
102
Issue
25
Year of publication
2000
Pages
E186 - E186
Database
ISI
SICI code
0009-7322(200012)102:25<E186:AAMOPI>2.0.ZU;2-B